Some atypical
antipsychotic drugs appear to improve cognitive function in
schizophrenia and since
acetylcholine (ACh) is of importance in cognition, we used in vivo microdialysis to examine the effects of
antipsychotics administered acutely (SC or IP) at pharmacologically comparable doses on ACh outflow in the hippocampus of the rat. The atypical
antipsychotics olanzapine and
clozapine produced robust increases in ACh up to 1500% and 500%, respectively. The
neuroleptics haloperidol,
thioridazine, and
chlorpromazine, as well as the atypical
antipsychotics risperidone and
ziprasidone produced modest increases in ACh by about 50-100%. Since most atypical
antipsychotics affect a variety of monoaminergic receptors, we examined whether selective
ligands for some of these receptors affect hippocampal ACh. Antagonists for the 5-HT(2A) (
MDL 100,907), the 5-HT(2C) (SB 242,084), the 5-HT(6) (Ro 04-6790), the D(2) (
raclopride) receptors, and the alpha(1)-adrenoceptors (
prazosin) modestly increased ACh by about 50%. The 5-HT(1A) agonist R-(+)-8-
OH-DPAT and the alpha(2)-adrenoceptor antagonist
yohimbine significantly increased ACh by about 100% and 50%, respectively. Thus,
olanzapine and
clozapine increased ACh to a greater extent than other tested
antipsychotics, explaining perhaps their purported beneficial effect in cognitive function in
schizophrenia. It appears that selective activity at each of the monoaminergic receptors studied is not the sole mechanism underlying the
olanzapine and
clozapine induced increases in hippocampal ACh.